Intrexon Corp. (XON)

5.16
NASDAQ : Health Technology
Prev Close 5.05
Day Low/High 5.03 / 5.27
52 Wk Low/High 3.95 / 14.79
Avg Volume 1.09M
Exchange NASDAQ
Shares Outstanding 162.07M
Market Cap 818.46M
EPS -3.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Dollar Tree Is One of 11 Stocks That Are Poised to Change Direction

Dollar Tree Is One of 11 Stocks That Are Poised to Change Direction

These names are showing bullish or bearish reversal patterns for the past week.

Programming Note

I will not be writing tomorrow but you will be in the very capable hands of "Meet" Bret Jensen on Wednesday. "Biotech Wednesday?" It's a hot group! Memo to Bret  --  what are your thoughts on FibroGen , ZIOPHARM Oncology and Intrexon  ? Thanks Broth...

Biowreck!

I am not sure if this has broader consequences, but biotech (especially of a speculative -- kind) is spitting the bit, again today.   I have already mentioned Allergan AGN (which I am buying now). Celgene CELG and Gilead Sciences GILD can't rally ei...

Takeaways and Observations

"She's a witch of trouble in electric blue, In her own mad mind she's in love with you. With you. Now what you gonna do? Strange brew, kill what's inside of you." -- Cream, Strange Brew     Strange brew!    You have probably forgotten October, 1987....

Added to Allergan on Weakness

Allergan , a day ahead of its earnings release, is down by over $4 on no apparent news, save a rotation out of biotech. (iShares Nasdaq Biotechnology is -3% or -$7 and we see individual equity declines in Celgene , Gilead , Acadia Pharmaceuticals , ...

The Good, the Bad and the Ugly (Mid-Afternoon Edition)

"It's not a joke, it's a rope, Tuco. Now I want you to get up there and put your head in that noose." -- Blondie, " The Good, the Bad and the Ugly" No "Takeaways" today as I have to prepare for my Tulane trip. So let's move to the abbreviated Monarc...

The Good, the Bad and the Ugly (EarlyAfternoon Edition)

"It's not a joke, it's a rope, Tuco. Now I want you to get up there and put your head in that noose." -- Blondie, " The Good, the Bad and the Ugly" No "Takeaways" today as I want to spend some time with my family right after the close. So let's move...

Takeaways And Observations

For the first time in six years the DJIA fell for the eighth consecutive day. That said the Nasdaq has risen in ten of the last thirteen trading sessions as Donald Trump may be making volatility and uncertainty great again. (For that divergence and ...

Takeaways & Observations

Risk happens fast.  Most don't short and shouldn't short -- it's a game that requires volumes of risk control.  However, I would continue to maintain well above-average cash positions.  Today was not a benign event, in my view.  Nor was it likely a ...

Takeaways & Observations

I wanted to start by congratulating El Capitan for his 12th anniversary for Mad Money tonight. Like the Energizer Bunny, he keeps going and going...  HIgh yield gets junky -- despite protestations from Merrill's junk department! I have been warning ...

My Takeaways and Observatons

"As to the markets, it trades like participants are sleeping off hangovers from partying hard during last night's Super Bowl thriller." -- "Is Another Lesson Soon to be Learned?"   With such little price action it seemed like a snore fest (see above...

My Takeaways and Observations

Risk happens fast.    Is the presidential honeymoon over? One of the 10 questions I asked myself today.    "The Return of the Orange Swan?"    Has Boca Biff done it again? Another top call?    Ten questions. In particular, read my comments on Steve ...

My Takeaways and Observations (Early Edition)

I had my most active day of the year trading. It was also my most profitable.   Regardless of one's market view, I continue to see more opportunities on the trading side vs. the investing side in the months ahead.   I started the day with a story re...

My Takeaways and Observations

"Who you tryin' to get crazy with, 'ese? Don't you know I'm loco?..." -- Cypress Hill, Insane in the Brain 2017 will be the year of "The Dude."    My favorite large-cap long Allergan  and short Caterpillar   for next year.  AGN closed up by $4(!) wh...

My Takeaways and Observations (2:45 p.m. EST edition)

"First gear, it's all right (Honda, Honda, go faster, faster) Second gear, I'll lean right (Honda, Honda, go faster, faster) Third gear, hang on tight (Honda, Honda, go faster, faster) Faster, it's all right." -- Beach Boys, "Little Honda"  With a b...

Takeaways and Observations

The markets moved lower from the "get go," though about the time Sixty Minutes was on last evening the S&P 500 futures were up 10 handles. (Futures closed down 2.5 handles)   Perhaps this is the start of a well due correction. Apropos, here is the q...

Beware the Fear of Missing Out (FOMO)

Beware the Fear of Missing Out (FOMO)

There's a striking lack of volatility, and that's a flashing red warning signal.

My Takeaways and Observations

"Well, they call you lady luck But there is room for doubt At times you have a very un-lady-like way Of running out..." -- Guys and Dolls, Luck Be A Lady (Frank Sinatra)  Trump will not likely Make Twitter Great Again.   I, bear.    Explaining my pr...

My Takeaways and Observations

What a strange day -- maybe even ominous.   This table tells it all.    The divergences I have been mentioning this week intensified today, with the technology-laden Nasdaq taken out to the shed and the Russell 2000 Index trading lower for the third...

My Takeaways and Observations

The important messages today are the developing divergences.    The strength in energy stocks (reflecting a $3.88 a barrel rise in crude oil) masked the underlying weakness in the broader markets. Stated simply, these divergences in breadth, highs/l...

My Takeaways and Observations (3:30 p.m. Edition)

It may be time to embrace the contrary.    First issue (!!): The Palm Beach Chronicles.   My weekly (brief) technical review of the markets -- cooling off ahead?    BTIG's Stockton is bullish and so, as I have expressed, are most others!   Campbell ...

Retail, Financials, Speculative Biotechs Getting Hit

This morning I warned about an overbought group of market sectors/leaders.   Thus far, (recent leaders) retail and financials are being taken out to the woodshed.   Speculative biotech, like Intrexon  , Portola Pharmaceuticals  , SAGE Therapeutics  ...

My Takeaways and Observations

Donald Trump may make illiquidity, volatility and uncertainty great again.    More "Penneys" from heaven, an analysis of the company's quarterly release.    Trade of the Week -- short Apple . Here and here.    I sold my retail long rentals for sick ...

My Takeaways and Observations

"Today I am asking myself ... Did the FANG names just peak the way iShares NASDAQ Biotechnology Index ETF IBB did in 2015 and Energy Select Sector SPDR ETFXLE did in 2014? The S&P 500 Index kept rising, but those two groups were done!"  -- Kass Diar...

Some Potential Positives Today

Some potential positives today: Strength in the Russell Index. Improving breadth. Improving Clinton odds by "538" and the London betting parlors. A great deal of pushback to my idea of a trading rally. Turnaround in large-cap biotech (Allergan , Cel...

So, What's in Store for Today?

I am happy to be standing in for Doug Kass this Friday morning as we end what has been a somewhat volatile week for trading. The big banks such as Citicorp and Wells Fargo are due to report before the bell this morning as we get further along into t...

Biowreck!

I warned in yesterday's Good, Bad and Ugly against taking shots on speculative stocks like biotech. Well, the biotech space is getting pummeled today. For example, Sage Therapeutics is down 11.8% as I write this, while Acadia Pharmaceuticals is off ...

4 Stocks to Buy in This Vulnerable Market

4 Stocks to Buy in This Vulnerable Market

This market is like a leaky helium balloon; watch out for sudden downdrafts.